Medicare Enrolled

Dr. Mary Vanderlick, MD

Neurology · Bellaire, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
6700 WEST LOOP S STE 400, Bellaire, TX 77401
7137046731
Registered in NPPES since 2006
NPI: 1144285842 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vanderlick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vanderlick? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vanderlick

Dr. Mary Vanderlick is a neurology specialist in Bellaire, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vanderlick performed 23,113 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Vanderlick received a total of $38,685 from 83 pharmaceutical and/or device companies across 1773 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vanderlick is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 3% volume in TX $38,685 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
23,113
Medicare services
Top 3% in TX for neurology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
15,900 $5 $12
Immune globulin infusion (Octagam)
This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form.
6,130 $33 $112
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
250 $91 $256
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
213 $59 $182
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
194 $17 $110
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
169 $131 $360
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
89 $52 $210
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
51 $80 $198
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
40 $151 $408
New patient office visit, complex (60-74 min) 37 $157 $443
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
26 $132 $336
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
14 $124 $353
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
27.7% high complexity
68.8% medium
3.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$38,685
Total received (2018-2024)
Avg $5,526/year across 7 years
Top 11% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
1,773
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,001
2023
$5,649
2022
$6,951
2021
$6,576
2020
$3,274
2019
$5,183
2018
$4,051

Payments by company (2024)

Amneal Pharmaceuticals LLC
$1,181
ABBVIE INC.
$871
Alexion Pharmaceuticals, Inc.
$479
UCB, Inc.
$475
Lundbeck LLC
$454
Grifols USA, LLC
$348
SK Life Science, Inc.
$327
PFIZER INC.
$279
Abbott Laboratories
$269
Biogen, Inc.
$267
Lilly USA, LLC
$261
Teva Pharmaceuticals USA, Inc.
$226
Otsuka America Pharmaceutical, Inc.
$224
Takeda Pharmaceuticals U.S.A., Inc.
$183
Genentech USA, Inc.
$178
SCILEX PHARMACEUTICALS INC.
$163
EMD Serono, Inc.
$153
Neurocrine Biosciences, Inc.
$143
Averitas Pharma Inc.
$112
Merz Pharmaceuticals, LLC
$80
Sumitomo Pharma America, Inc.
$73
Zevra Therapeutics Inc
$58
ACADIA Pharmaceuticals Inc
$43
ARGENX US, INC.
$38
Novartis Pharmaceuticals Corporation
$36
CSL Behring
$28
SpringWorks Therapeutics, Inc.
$24
Azurity Pharmaceuticals, Inc.
$19
Aucta Pharmaceuticals, Inc.
$9
Top 3 companies account for 36.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,401
Abbott Laboratories
$2,182
Biogen, Inc.
$2,166
Teva Pharmaceuticals USA, Inc.
$1,953
UCB, Inc.
$1,922
Biohaven Pharmaceuticals, Inc.
$1,775
SK Life Science, Inc.
$1,620
AbbVie Inc.
$1,484
Amneal Pharmaceuticals LLC
$1,465
Genentech USA, Inc.
$1,453
Alexion Pharmaceuticals, Inc.
$1,440
Novartis Pharmaceuticals Corporation
$1,295
Grifols USA, LLC
$1,222
ABBVIE INC.
$1,125
Neurocrine Biosciences, Inc.
$1,057
PFIZER INC.
$1,052
GENZYME CORPORATION
$996
Lilly USA, LLC
$962
EMD Serono, Inc.
$934
Allergan, Inc.
$871
CSL Behring
$727
Lundbeck LLC
$709
Supernus Pharmaceuticals, Inc.
$589
Allergan Inc.
$578
Bausch Health US, LLC
$469
Takeda Pharmaceuticals U.S.A., Inc.
$468
Biohaven Pharmaceutical Holding Company Ltd.
$464
ACADIA Pharmaceuticals Inc
$422
Averitas Pharma Inc.
$369
ARBOR PHARMACEUTICALS, INC.
$280
Avanir Pharmaceuticals, Inc.
$262
Otsuka America Pharmaceutical, Inc.
$247
GRT US Holding, Inc.
$235
Janssen Pharmaceuticals, Inc
$231
Acorda Therapeutics, Inc
$221
Almatica Pharma LLC
$172
SCILEX PHARMACEUTICALS INC.
$163
Greenwich Biosciences, Inc.
$148
Merz Pharmaceuticals, LLC
$135
ARGENX US, INC.
$131
CATALYST PHARMACEUTICALS, INC.
$123
Boston Scientific Corporation
$119
Assertio Therapeutics, Inc.
$119
Akcea Therapeutics, Inc.
$115
Upsher-Smith Laboratories LLC
$102
GE Healthcare
$99
Scilex Pharmaceuticals Inc.
$90
Merz North America, Inc.
$80
ASSERTIO THERAPEUTICS, Inc.
$80
Kedrion Biopharma Inc.
$79
Corium, LLC
$74
Sumitomo Pharma America, Inc.
$73
Adamas Pharmaceuticals, Inc.
$71
Kyowa Kirin, Inc.
$67
Medtronic USA, Inc.
$65
BOSTON SCIENTIFIC CORPORATION
$61
Arbor Pharmaceuticals, Inc.
$59
Zevra Therapeutics Inc
$58
GE HEALTHCARE
$57
E.R. Squibb & Sons, L.L.C.
$54
AbbVie, Inc.
$46
Octapharma USA, Inc.
$46
Harmony Biosciences LLC
$42
Impax Laboratories, Inc.
$41
Medtronic, Inc.
$39
Zyla Life Sciences
$39
Horizon Therapeutics plc
$38
Promius Pharma LLC
$35
Currax Pharmaceuticals LLC
$35
Genentech, Inc.
$31
Celgene Corporation
$29
EISAI INC.
$29
SpringWorks Therapeutics, Inc.
$24
Jazz Pharmaceuticals Inc.
$21
Mitsubishi Tanabe Pharma America, Inc.
$20
Strongbridge US INC.
$20
Azurity Pharmaceuticals, Inc.
$19
IMPEL PHARMACEUTICALS INC.
$19
LivaNova USA, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$16
MDD US Operations, LLC
$15
Eisai Inc.
$13
Aucta Pharmaceuticals, Inc.
$9
Top 3 companies account for 17.4% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ACTIVA PC · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · COPAXONE · CREXONT · Cambia · DUOPA · Duopa · EMGALITY · EUCRISA · Epidiolex · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · GRALISE · Gammaked · Gamunex-C · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INVOKANA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NAPRELAN · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Olpruva · Ongentys · PANZYGA · PLEGRIDY · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPECTRA WAVEWRITER · SPRIX · Soliris · TECFIDERA · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XARELTO · XCOPRI · XEOMIN · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Bellaire?
Compare neurologists in the Bellaire area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
387
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
BEHAVIORAL HOSPITAL OF BELLAIRE
1.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vanderlick is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vanderlick experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Vanderlick performed 15,900 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Vanderlick receive payments from pharmaceutical companies?
Yes. Dr. Vanderlick received a total of $38,685 from 83 companies across 1,773 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vanderlick's costs compare to other neurologists in Bellaire?
Dr. Vanderlick's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vanderlick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →